These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33252245)

  • 1. CRISPR and Long-Read Sequencing: A Perfect Match.
    Ameur A
    CRISPR J; 2020 Dec; 3(6):425-427. PubMed ID: 33252245
    [No Abstract]   [Full Text] [Related]  

  • 2. Analyzing CRISPR genome-editing experiments with CRISPResso.
    Pinello L; Canver MC; Hoban MD; Orkin SH; Kohn DB; Bauer DE; Yuan GC
    Nat Biotechnol; 2016 Jul; 34(7):695-7. PubMed ID: 27404874
    [No Abstract]   [Full Text] [Related]  

  • 3. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.
    Burmistrz M; Dudek B; Staniec D; Rodriguez Martinez JI; Bochtler M; Potempa J; Pyrc K
    J Bacteriol; 2015 Aug; 197(16):2631-41. PubMed ID: 26013482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSFinder: high throughput CRISPR-Cas target sites prediction tool.
    Upadhyay SK; Sharma S
    Biomed Res Int; 2014; 2014():742482. PubMed ID: 25089276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
    Liang Z; Zhang K; Chen K; Gao C
    J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR Surveillance Turns Transposon Taxi.
    Wiegand T; Wiedenheft B
    CRISPR J; 2020 Feb; 3(1):10-12. PubMed ID: 32091255
    [No Abstract]   [Full Text] [Related]  

  • 8. CRISPR on the Move in 2019.
    Barrangou R
    CRISPR J; 2019 Feb; 2():1-2. PubMed ID: 31021232
    [No Abstract]   [Full Text] [Related]  

  • 9. [An history of the CRISPR-Cas systems discovery].
    Pourcel C
    Biol Aujourdhui; 2017; 211(4):247-254. PubMed ID: 29956651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An active immune defense with a minimal CRISPR (clustered regularly interspaced short palindromic repeats) RNA and without the Cas6 protein.
    Maier LK; Stachler AE; Saunders SJ; Backofen R; Marchfelder A
    J Biol Chem; 2015 Feb; 290(7):4192-201. PubMed ID: 25512373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR Jumps in New Directions.
    LeMieux J
    CRISPR J; 2019 Dec; 2(6):354-356. PubMed ID: 31860346
    [No Abstract]   [Full Text] [Related]  

  • 13. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
    Maier LK; Marchfelder A; Randau L
    Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
    [No Abstract]   [Full Text] [Related]  

  • 14. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs in the Porphyromonas gingivalis CRISPR-Cas I-C System.
    Burmistrz M; Rodriguez Martinez JI; Krochmal D; Staniec D; Pyrc K
    J Bacteriol; 2017 Dec; 199(23):. PubMed ID: 28893837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Biology and Application Areas of CRISPR Technologies.
    Adli M
    J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.
    Smith C; Gore A; Yan W; Abalde-Atristain L; Li Z; He C; Wang Y; Brodsky RA; Zhang K; Cheng L; Ye Z
    Cell Stem Cell; 2014 Jul; 15(1):12-3. PubMed ID: 24996165
    [No Abstract]   [Full Text] [Related]  

  • 17. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-mediated direct mutation of cancer genes in the mouse liver.
    Xue W; Chen S; Yin H; Tammela T; Papagiannakopoulos T; Joshi NS; Cai W; Yang G; Bronson R; Crowley DG; Zhang F; Anderson DG; Sharp PA; Jacks T
    Nature; 2014 Oct; 514(7522):380-4. PubMed ID: 25119044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
    Bradde S; Mora T; Walczak AM
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.